Drug Type Small molecule drug |
Synonyms Aranidipine (JAN/INN), Bec, MPC 1304 + [2] |
Target |
Mechanism Cav2.1 inhibitors(calcium voltage-gated channel subunit alpha1 A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date (01 Jan 1996), |
Regulation- |
Molecular FormulaC19H20N2O7 |
InChIKeyNCUCGYYHUFIYNU-UHFFFAOYSA-N |
CAS Registry86780-90-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01562 | Aranidipine |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Angina Pectoris | JP | - | 27 Apr 1997 |
Hypertension | - | - | 01 Jan 1996 |
Phase 3 | 109 | The Bashir™ Endovascular Catheter+r-tPA | mbqwrceoam(awfhyyudir) = qwapcdebvh twsdbpkxqw (byzxlqyxmq, lsjnrteefb - cydhyzhpno) View more | - | 20 Apr 2023 | ||
Phase 1 | 9 | The Bashir™ Endovascular Catheter+r-tPA | tgkgahajsp(aarqxqgyln) = iwnrchvimu ueqkchdmpb (wmdzjtooxc, zgntwrvnvh - iauatocblw) View more | - | 30 Mar 2023 |